RENO, Nev., Mar 29, 2006 (BUSINESS WIRE) -- Lifeline Biotechnologies, Inc. (Pink Sheets: LBTN) today announced a common stock dividend which will be issued to its shareholders of record as of April 14, 2006. The stock dividend will total approximately 50 Million unrestricted shares of LBTN. Lifeline Biotechnologies shareholders are expected to receive approximately one and a half shares of LBTN for each ten shares already owned on the record date. "This stock dividend to shareholders is a reward for their continued support as we focus on the increased marketing efforts of our MastaScope(TM) and the development of our First Warning System(TM) and OvaScope(TM). We are very pleased to be in a position to give back to our loyal shareholders and show our appreciation," stated Jim Holmes, CEO of Lifeline Biotechnologies, Inc.
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of a number of disease conditions. The company's technologies, designed to assist in the early detection of cancers, deal with cutting edge innovation to assist practicing physicians in the delivery of quality medical care. The MastaScope(TM) is used to assist in the early detection of cancer and other abnormalities of the breast. The MastaScope(TM) has completed development and has entered the marketplace in the US and internationally. The First Warning System(TM) for assisting in the early detection of breast cancer and the OvaScope(TM) for assisting in the early detection of ovarian cancer are continuing to be developed by the company. More information is available at the company's website: www.lbti.com.
Safe Harbor This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE: Lifeline Biotechnologies, Inc.
CONTACT: for Lifeline Biotechnologies, Inc. Big Apple Consulting USA, Inc. Rodney Marvel, 407-884-0444 1-866-THE-APPL(E)
Copyright Business Wire 2006
Posted by bowlegtroy on :
up 87% now
Posted by realperson on :
wow I had just 166,000 shares sitting there and they sold on an old sell order at.0065 B-4 I even new it .Far Out This will be fun to watch now
Posted by bowlegtroy on :
up over 180% so far....nice news rocks!
Posted by hurricanematt on :